Potential efficacy of dopamine loaded-PVP/PAA nanogel in experimental models of Parkinsonism: possible disease modifying activity.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Biomedical Materials Research. Part A

• Publication date

  2015-05-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1002/jbm.a.35312PMID 25131611
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroprotective effect of EGb761® and low-dose whole-body γ-irradiation in a rat model of Parkinson’s disease

  2015cited by this paper
• Radiation-induced synthesis of nanogels based on poly(N-vinyl-2-pyrrolidone)—A review

  2014cited by this paper
• Preparation of water dispersible, fluorescent Ag–PAA–PVP hybrid nanogels and their optical properties

  2014cited by this paper
• Methotrexate-loaded chitosan nanogels as 'Trojan Horses' for drug delivery to brain: preparation and in vitro/in vivo characterization.

  2013cited by this paper
• Controlling the size and swellability of stimuli-responsive polyvinylpyrrolidone–poly(acrylic acid) nanogels synthesized by gamma radiation-induced template polymerization

  2013cited by this paper
• Developing the potential ophthalmic applications of pilocarpine entrapped into polyvinylpyrrolidone-poly(acrylic acid) nanogel dispersions prepared by γ radiation.

  2013cited by this paper
• Efficacy and Safety of Nasal Administration of “Na-no-L-DOPA” Based on PLGA Nanoparticles

  2012cited by this paper
• Supramolecular devices to improve the treatment of brain diseases.

  2011cited by this paper
• Polymer nanoparticles: Preparation techniques and size-control parameters

  2011cited by this paper
• Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery.

  2011cited by this paper
• Preparation and in-vitro evaluation of indomethacin nanoparticles

  2010cited by this paper
• Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain.

  2009cited by this paper
• Spectrophotometric Determination of Dopamine Hydrochloride in Pharmaceutical, Banana, Urine and Serum Samples by Potassium Ferricyanide-Fe(III)

  2009cited by this paper
• A highly reproducible rotenone model of Parkinson's disease.

  2009cited by this paper
• Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.

  2008cited by this paper
• Template Polymerization to Fabricate Hydrogen-Bonded Poly(acrylic acid)/Poly(vinylpyrrolidone) Hollow Microcapsules with a pH-Mediated Swelling−Deswelling Property

  2007cited by this paper
• Alpha-lipoic acid differently affects the reserpine-induced oxidative stress in the striatum and prefrontal cortex of rat brain.

  2007cited by this paper
• Characterization of nanoparticles for therapeutics.

  2007cited by this paper
• Diagnosis and treatment of Parkinson disease: molecules to medicine.

  2006cited by this paper
• Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD).

  2006cited by this paper
• Syntheses and the Study of Strongly Hydrogen-Bonded Poly(vinylphenol-b-vinylpyridine) Diblock Copolymer through Anionic Polymerization

  2006cited by this paper
• Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions.

  2004cited by this paper
• L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats.

  2004cited by this paper
• Biomarkers of neurodegenerative disorders: How good are they?

  2004cited by this paper
• Mechanism of Toxicity in Rotenone Models of Parkinson's Disease

  2003cited by this paper
• Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production*

  2003cited by this paper
• Mitochondrial Mechanisms of Neural Cell Death and Neuroprotective Interventions in Parkinson's Disease

  2003cited by this paper
• Possible mechanism of action in melatonin attenuation of haloperidol-induced orofacial dyskinesia.

  2003cited by this paper
• Formulation and in vitro-in vivo evaluation of piribedil solid lipid micro- and nanoparticles

  2001cited by this paper
• Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease

  2000cited by this paper
• Chronic systemic pesticide exposure reproduces features of Parkinson's disease

  2000cited by this paper
• Increased striatal dopamine turnover following acute administration of rotenone to mice.

  2000cited by this paper
• Mouse models of α-synucleinopathy and Lewy pathology

  2000cited by this paper
• Mouse models of alpha-synucleinopathy and Lewy pathology.

  2000cited by this paper
• Investigation of the Swelling Response and Loading of Ionic Microgels with Drugs and Proteins: The Dependence on Cross-Link Density

  1999cited by this paper
• Microgels-Intramolecularly Crossünked Macromolecules with a Globular Structure

  1998cited by this paper
• Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat.

  1997cited by this paper
• Analytical evaluation of high energy phosphate determination by high performance liquid chromatography in myocardial tissue.

  1994cited by this paper
• Hamster cell mutants unable to grow on galactose and exhibiting an overlapping complementation pattern are defective in the electron transport chain.

  1981cited by this paper
• Determination of malonaldehyde precursor in tissues by thiobarbituric acid test.

  1978cited by this paper
• Improved method for the determination of blood glutathione.

  1963cited by this paper
• Treatment of Hypertension with Reserpine,with Reserpine in Combination with Pentapyrrolidinium,and with Reserpine in Combination with Veratrum Alkaloids

  1955cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Nanogels as multifunctional platforms: from drug delivery to gene therapy

  2025cites this paper
• Effect of E-Beam Irradiation on Solutions of Fullerene C60 Conjugate with Polyvinylpyrrolidone and Folic Acid

  2025cites this paper
• Advances in hydrogel for diagnosis and treatment for Parkinson’s disease

  2025cites this paper
• From Bench to Brain: Translating EV and Nanocarrier Research into Parkinson’s Disease Therapies

  2025cites this paper
• Designing and Formulation of Nanocarriers for "Alzheimer's and Parkinson's" Early Detection and Therapy.

  2024cites this paper
• A Comprehensive Review on Repurposing the Nanocarriers for the Treatment of Parkinson's Disease: An Updated Patent and Clinical Trials.

  2024cites this paper
• Smart nanogels as promising platform for delivery of drug, gene, and vaccine; therapeutic applications and active targeting mechanism

  2024cites this paper
• Performance of graphene-functionalized nano chitosan in ternary polymeric nanocomposites for physical and biological applications

  2024cites this paper
• Unraveling the Ties: Type 2 Diabetes and Parkinson's Disease - A Nano-Based Targeted Drug Delivery Approach.

  2024cites this paper
• Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease

  2024cites this paper
• “To Be or Not to Be” of a Polymer Nanogel—Unravelling the Relationship of Product Properties vs. Synthesis Conditions Governing the Radiation Crosslinking of Poly(acrylic acid) Using GPC/SEC—MALLS

  2023cites this paper
• Nanogel-based drug delivery system as a treatment modality for diverse diseases: Are we there yet?

  2023cites this paper
• Macromolecular design of pH sensitive, folic acid functionalized double hydrophilic block copolymer nanogels as methotrexate carriers to breast cancer cells

  2023cites this paper
• Injectable nanogel systems for brain drug delivery

  2023cites this paper
• Nanogels as novel drug nanocarriers for CNS drug delivery

  2023cites this paper
• Advances in Hydrogel-Based Drug Delivery Systems for Parkinson's Disease

  2022cites this paper
• Theoretical and Applied Concepts of Nanocarriers for the Treatment of Parkinson's Diseases

  2022cites this paper
• Novel Nanoparticles Based on N,O-Carboxymethyl Chitosan-Dopamine Amide Conjugate for Nose-to-Brain Delivery

  2022cites this paper
• Nanomedicine in the Face of Parkinson’s Disease: From Drug Delivery Systems to Nanozymes

  2022cites this paper
• Hydrogels for brain repair: application to Parkinson’s disease

  2022cites this paper
• On the Mechanism and Kinetics of Synthesizing Polymer Nanogels by Ionizing Radiation-Induced Intramolecular Crosslinking of Macromolecules

  2021cites this paper
• Nose-to-brain delivery: a comparative study between carboxymethyl chitosan based conjugates of dopamine.

  2021cites this paper
• Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson’s Disease

  2021cites this paper
• Dopamine-loaded lipid based nanocarriers for intranasal administration of the neurotransmitter: a comparative study.

  2021cites this paper
• Nanogel Synthesis by Irradiation of Aqueous Polymer Solutions

  2021cites this paper
• Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases

  2021cites this paper
• Hydrogel systems and their role in neural tissue engineering

  2020cites this paper
• Nanogels synthesized by radiation-induced intramolecular crosslinking of water-soluble polymers

  2020cites this paper
• Synthesis and characterization of novel chitosan-dopamine or chitosan-tyrosine conjugates for potential nose-to-brain delivery.

  2020cites this paper
• Dopamine-loaded poly (butyl cyanoacrylate) nanoparticles reverse behavioral deficits in Parkinson's animal models.

  2020cites this paper
• On the nature of macroradicals formed upon radiolysis of aqueous poly(N-vinylpyrrolidone) solutions

  2020cites this paper
• Micro- to Nanoscale Bio-Hybrid Hydrogels Engineered by Ionizing Radiation

  2020cites this paper
• Investigation of the Structural Properties of Dopamine-Loaded Poly(butyl cyanoacrylate) Nanosystem

  2020cites this paper
• Current trends and concepts in the design and development of nanogel carrier systems

  2018cites this paper
• Protection of dopamine towards autoxidation reaction by encapsulation into non-coated- or chitosan- or thiolated chitosan-coated-liposomes.

  2018cites this paper
• Nanoneuromedicines for Neurodegenerative Diseases

  2018cites this paper
• Preparation of nanogels by radiation-induced cross-linking of interpolymer complexes of poly (acrylic acid) with poly (vinyl pyrrolidone) in aqueous medium

  2018cites this paper
• Nanobiomaterials’ applications in neurodegenerative diseases

  2017cites this paper
• Nanotechnology Based Drug Delivery System and its Applications

  2017cites this paper
• A facile, efficient and “green” route to pH-responsive crosslinked poly(methacrylic acid) nanoparticles

  2017cites this paper
• The Potential of Stimuli-Responsive Nanogels in Drug and Active Molecule Delivery for Targeted Therapy

  2017cites this paper
• Nanoparticulate strategies for the treatment of polyglutamine diseases by halting the protein aggregation process†

  2017cites this paper
• Ultrasonically assisted preparation of poly(acrylic acid)/calcium phosphate hybrid nanogels as pH-responsive drug carriers.

  2017cites this paper
• Natural and synthetic polymers for drug delivery and targeting

  2016cites this paper
• Controlled in Vitro Release of Levodopa from Sodium Alginate Membranes

  2016cites this paper
• Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.

  2015cites this paper